August 21st, 2014 · Leave a Comment
The future of health care needs to provide answers to the people who need them most -- the patients living with diseases and conditions that threaten their health and their lives. How is Mayo Clinic addressing this need in today's challenging health care environment? One solution lies in the efforts of Mayo Clinic Ventures and Mayo physicians and scientists who are working towards mining inventions, ideas and discoveries that will truly transform health care by improving the health and well-being of patients throughout the world.
Here's a recent post published on Mayo's In the Loop blog, which uniquely captures how Mayo Clinic Ventures makes it all happen:
"When you think about entrepreneurs and breakthrough inventions, you might imagine someone tinkering with a gadget (perhaps a doohickey or thingamajig) in a garage. You might not, however, picture a Mayo researcher tinkering with peptides to fight hypertension, creating a tracking system for viruses, or fashioning a tool to make medical information easier to read for those with poor vision. But our friends at Mayo Clinic Ventures would like us to, and a recent article series in the Minneapolis/St. Paul Business Journal gets under the hood to explore why.
Mayo's efforts to encourage entrepreneurship and support startups is not only good for medicine, but as writer Katharine Grayson suggests, bringing new ideas to the marketplace also has the potential to 'broadly impact Minnesota’s economy, with more Mayo business offspring growing up in (our own) backyard.' Jim Rogers, chair of Mayo Clinic Ventures, which commercializes Mayo Clinic technologies, tells Grayson that has meant a bit of a culture shift. And it’s required the assistance of efforts like the Mayo Clinic Business Accelerator, which provides collaborative space for new companies, venture capital firms and entrepreneurs.
To illustrate the potential of entrepreneurial endeavors, Grayson profiles three startups in a series called 'Made at Mayo.' The first article, “Mayo professor doubles as founder of text tech company,” chronicles the work of Randall Walker, M.D., Infectious Diseases, who started a company to create 'software that converts text into an easier-to-read format.' He was 'inspired by his own family history … to help people with low vision read easier,' Grayson writes. Walker Reading Technologies recently moved into the Business Accelerator space and is now working with Mayo 'to research how his text-conversion technology, called Live Ink, could make electronic medical records easier to read and manage.'
— Mayo Clinic Ventures (@MayoInvents) August 5, 2014
In another piece, called “Oncology professor launches startup to track cells and viruses,” the Biz Journal explores the work of Mayo’s Kah Whye Peng, Ph.D., to turn 'her scientific research into the foundation for a growing startup company.' Imanis Life Sciences 'sells tools and services that create a GPS-like tracking system for cells and viruses.' That allows researchers to 'use imaging technology to monitor therapies’ progress inside living animals.' And a piece called “Zumbro uses custom peptides to battle hypertension” documents the work of John Burnett, M.D., and Horng Chen, M.D. 'Their latest venture, Zumbro Discovery Inc.,' Grayson writes, 'uses peptides to treat high blood pressure in patients who haven’t benefited from traditional drugs.' Dr. Burnett says the company expects to begin clinical trials yet this year, expects to grow significantly, and its 'goal is to be the next Amgen.'
Read more about the big plans for these ventures, as well as the business behind the business, in the Business Journal series."
August 13th, 2014 · Leave a Comment
This post originally appeared in the Mayo Medical Laboratories blog.
Franklin Cockerill, M.D., chair of the Mayo Clinic Department of Laboratory Medicine and Pathology, participated in the 21st Century Cures Roundtable on Personalized Medicine hosted by the U.S. House of Representatives Energy and Commerce Committee on Wednesday, July 23.
Throughout Dr. Cockerill’s remarks, he emphasized the importance of providing proper government funding for research and regulatory bodies, harmonizing regulations, emphasizing clinical validation, ensuring patient safety, and encouraging innovation. A summary of Dr. Cockerill’s remarks have been embedded below.
According to the committee’s website, the 21st Century Cures Roundtable next brings together industry leaders to, “discuss how the rise of personalized medicine and advances in science and technology can shape the health care system in the 21st century. Specifically, the roundtable will explore how genomic sequencing and diagnostic testing, as well as the regulation of these continually evolving areas, affect innovative product development and delivery.”
Key Points from Dr. Cockerill's Remarks:
Focus on harmonizing regulations, emphasizing clinical validation, ensuring patient safety & encouraging innovation. - Cockerill #path2cures
— Mayo Medical Labs (@mayocliniclabs) July 23, 2014
— Mayo Medical Labs (@mayocliniclabs) July 23, 2014
Challenges: Govt funding of scientific discovery & translating discoveries to clinical tests that benefit patients.- Cockerill #Path2Cures
— Mayo Medical Labs (@mayocliniclabs) July 23, 2014
July 30th, 2014 · Leave a Comment
Mayo Clinic wants to help 200 million patients by 2020. That's the future of health care vision of John Noseworthy, M.D., president and CEO of Mayo Clinic. He recently shared his plans with The Daily Briefing on how to accomplish this goal by:
1) Scaling Mayo Clinic's knowledge with the continued growth of the Mayo Clinic Care Network to provide seamless, high-quality, team-based care.
2) Applying innovative science and data to evaluate the quality, safety and value of health care globally and improve real-world experiences for patients through the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery.
3) Partnering with Optum to launch Optum Labs, an open, collaborative research and development facility, to collect and analyze patient data that will determine how health care providers can provide the safest care with the best patient outcomes.
Read the entire interview here to learn more about these plans as well as Dr. Noseworthy's recommendations for those who aspire to become health care leaders.
July 23rd, 2014 · Leave a Comment
Wait no more for the transition to genomic medicine as we look towards the future of health care. It’s here, and it’s changing the way doctors care for everything from cancer to diabetes and Alzheimer’s disease. But the reality is that most physicians report insufficient knowledge to maximize the benefits of these powerful new tools on behalf of their patients.
Mayo Clinic is changing that with the Individualizing Medicine Conference series, the world’s largest meeting geared towards helping providers of all stripes discover and discuss the latest tools in individualized medicine. The goal is to cultivate new skills in providers, pharmacists and researchers so that they take those techniques back to their practices and help improve care for patients around the world. [...]
July 16th, 2014 · Leave a Comment
The future of health care in the United States requires modernization of clinical trial regulations and processes. On July 9, I had the opportunity to deliver that message and stress its importance in testimony on behalf of Mayo Clinic before the U.S. House of Representatives Energy and Commerce Subcommittee on Health. As part of the full Committee’s 21st Century Cures Initiative, the Health Subcommittee held a hearing focused on policy issues surrounding clinical trials. I applaud the Committee’s interest in this issue and urge continued focus on the need for reform to reduce the length of time from target discovery to approval of new drugs and treatments.
As I reported to the Committee, the average length of time from target discovery to approval of a new drug currently averages approximately 14 years, the failure rate exceeds 95 percent, and the cost per successful drug exceeds $2 billion, after adjusting for all of the failures. This situation must change.
July 10th, 2014 · Leave a Comment
The future of health care is moving towards providing safe, quality care via telemedicine; however, the patchwork of state-by-state medical licensing rules inhibit the delivery of medical services through telemedicine. Patients should not have to take a road trip to access Mayo Clinic’s medical expertise and knowledge. “Cross-border licensure is a strategic imperative as we move forward in this brave new world,” said Kathleen Harrington, chair of government relations at Mayo.
Mayo’s vast cadre of subspecialists — who diagnose and treat very rare and complex conditions — should be available to physicians in any location to help them bring safer care, better outcomes, fewer redundancies, and ultimately higher quality and cost savings for their patients. Mayo Clinic provides subspecialty expertise through telemedicine to physicians in its Mayo Clinic Care Network of more than two dozen hospitals and health systems, including Dartmouth-Hitchcock in New Hampshire; NorthShore University HealthSystem in the suburbs of Chicago; Baptist Health Care in Pensacola, Fla.; and ThedaCare in Wisconsin.
In stroke telemedicine, also called telestroke, neurologists remotely evaluate people who have had acute strokes and make diagnoses and treatment recommendations to emergency medicine doctors at other sites. Having a prompt neurological evaluation increases the possibility that a patient may receive clot-dissolving therapies (thrombolytics) or other clot-retrieving procedures in time to reduce disability and death resulting from stroke.
Researchers recently found that telestroke appears to be cost-effective for society, and study findings were published in The American Journal of Managed Care. "This study shows that a hub-and-spoke telestroke network is not only cost-effective from the societal perspective, but it's cost-saving,” says neurologist Bart Demaerschalk, M.D., director of the Mayo Clinic Telestroke Program and the lead investigator of the telestroke cost-effectiveness study. “We can assess medical services, like telemedicine, in terms of the net costs to society for each year of life gained."
The study estimates that compared with no network, a modeled telestroke system consisting of a single hub and seven spoke hospitals may result in the appropriate use of more clot-busting drugs and more catheter-based interventional procedures and other stroke therapies, with more stroke patients discharged home independently. Despite upfront and maintenance expenses, the entire network of hospitals realizes a greater total cost savings.
The improvement in outcomes is associated with reduced resource use (inpatient rehabilitation, nursing homes, caregiver time). Although treating patients in a telestroke network is associated with higher upfront costs due to the setup of the telestroke network and more costly treatments during the initial hospitalizations, it can potentially lead to cost savings over a lifetime. “The results serve to inform government organizations, insurers, health care institutions, practitioners, patients and the general public that an upfront investment in telemedicine and stroke network personnel can be justified in our health system,” Dr. Demaerschalk says.
For more information on telemedicine, please view the videos featured in the following Mayo Clinic YouTube playlist:
July 2nd, 2014 · Leave a Comment
As the future of health care moves forward, patients, providers and policymakers have converged on the shared goal of creating value in the U.S. health care system — high quality health care that contributes to favorable patient-centered outcomes and lower costs. Although these various stakeholders may define value in slightly different ways, all views are important and interrelated.
Since the Affordable Care Act was passed four years ago, the government has made efforts to identify innovative models of care tied to quality and reimbursement. However, it remains difficult to define and measure the value of care provided by individual providers or health care organizations. Current measures of clinical performance may not be producing better quality or reducing costs. For example, emerging data suggest that measuring individual provider performance (i.e. achieving optimal blood hemoglobin A1C levels) bears little relation to the health of patients with diabetes mellitus.
June 25th, 2014 · Leave a Comment
Can social media sites such as Google+, Facebook, and Twitter impact the future of health care? Ask the Mayo Clinic experts and over 300 participants who joined last week's Twitter chat, #CIMChat, to discuss immunotherapy, and their resounding answer would be, "yes!"
Health care Twitter chats have the potential to reach millions of individuals on a wide variety of topics ranging from general health and wellness to cutting-edge research and treatment options for rare diseases.
We're ready to tweet from @MayoClinic Bring your ?s to the #CIMchat w/ @TIME's @AliceParkNY pic.twitter.com/nqr3L7lRKa
— Dana Wirth Sparks (@danawsparks) June 18, 2014